MITRAL REGURGITATION
Clinical trials for MITRAL REGURGITATION explained in plain language.
Never miss a new study
Get alerted when new MITRAL REGURGITATION trials appear
Sign up with your email to follow new studies for MITRAL REGURGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve offers hope without major surgery
Disease control Recruiting nowThis study is testing a new device called the Cephea Mitral Valve System for people with a leaky or narrowed mitral valve in their heart. The goal is to see if this less invasive procedure, done through a catheter, is safe and can effectively reduce the severity of the valve prob…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for High-Risk patients with leaky heart valves
Disease control Recruiting nowThis study is testing a new device called the HighLife valve for people with a severely leaking mitral heart valve who are too high-risk for traditional open-heart surgery. Doctors will implant the new valve using a thin tube (catheter) inserted through a vein, aiming to fix the …
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: HighLife SAS • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for High-Risk heart patients: testing a lifesaving valve procedure
Disease control Recruiting nowThis study is testing a less invasive procedure to replace a severely calcified mitral heart valve in patients who are too high-risk for standard open-heart surgery. Doctors will implant a new valve using a catheter inserted through a vein, aiming to improve symptoms and reduce h…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Mayra Guerrero • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for untreatable leaky heart valves
Disease control Recruiting nowThis study is testing a new device called the SAPIEN M3 System to replace a leaky mitral heart valve without major open-heart surgery. It's for people with severe symptoms from their leaky valve who are not good candidates for standard surgical or other catheter-based treatments.…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can fixing a floppy heart valve stop dangerous rhythms?
Disease control Recruiting nowThis study aims to see if surgery to repair a leaky, floppy mitral heart valve can reduce dangerous irregular heartbeats and heart scarring in patients who have both conditions. Researchers will follow 90 patients needing this standard surgery, checking their heart rhythms and pe…
Matched conditions: MITRAL REGURGITATION
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New heart valve offers hope without major surgery
Disease control Recruiting nowThis study is testing a new device called the Cephea Mitral Valve System. It aims to treat people with a leaky or narrowed heart valve using a less invasive catheter procedure instead of open-heart surgery. The main goals are to see if the procedure is safe and if it successfully…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New heart valve procedure offers hope without major surgery
Disease control Recruiting nowThis study is testing a new device called the Tioga TMVR System that replaces leaky mitral heart valves through a small tube inserted in the leg, avoiding open-heart surgery. The trial will enroll 30 patients with severe, symptomatic mitral regurgitation who are not ideal candida…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Tioga Cardiovascular, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New heart failure plan aims to pinpoint best candidates for Life-Changing valve clip
Disease control Recruiting nowThis study is testing a new, step-by-step treatment plan for people with heart failure and a specific leaky heart valve. It aims to see if this plan helps doctors better identify which patients are most likely to benefit from a minimally invasive procedure called MitraClip. The s…
Matched conditions: MITRAL REGURGITATION
Sponsor: Inova Health Care Services • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Heart valve repair patients tested for safer blood thinner approach
Disease control Recruiting nowThis study aims to find the safest blood thinner approach for patients who have undergone a minimally invasive heart valve repair procedure. Researchers will compare different medication strategies in over 1,000 patients to determine which approach best balances the risk of bleed…
Matched conditions: MITRAL REGURGITATION
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for High-Risk heart patients: implant trial for untreatable valve leak
Disease control Recruiting nowThis trial is testing a new device called the Intrepid TMVR System for people with a severely leaking heart valve (mitral regurgitation) who are too high-risk for standard valve repair or replacement surgery. Doctors will implant the new valve using a thin tube (catheter) inserte…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Heart valve patients face blood thinner dilemma: new study seeks answers
Disease control Recruiting nowThis study aims to find the best blood thinner strategy for patients who have undergone a minimally invasive heart valve repair and also need long-term blood thinners. Researchers will compare different approaches to balance the risks of dangerous bleeding against the risks of st…
Matched conditions: MITRAL REGURGITATION
Phase: PHASE4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New heart valve device enters human testing
Disease control Recruiting nowThis early-stage study is testing a new device called the ReValve System to replace leaky mitral valves in the heart. The trial will enroll 20 adults with severe mitral regurgitation who are experiencing symptoms like shortness of breath and fatigue. Researchers will assess wheth…
Matched conditions: MITRAL REGURGITATION
Phase: PHASE1 • Sponsor: ReValve Solutions Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New device offers hope for fixing leaky heart valves without major surgery
Disease control Recruiting nowThis study is testing a new device called the CardioMech MVRS to see if it is safe and works well for repairing a leaky mitral heart valve. It is for people with a significant leak who are at intermediate or high risk for traditional open-heart surgery. The goal is to control the…
Matched conditions: MITRAL REGURGITATION
Phase: NA • Sponsor: CardioMech AS • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Heart scans reveal hidden gender gaps in valve disease
Knowledge-focused Recruiting nowThis study aims to understand how heart valve disease affects men and women differently using advanced heart scans. Researchers will analyze detailed heart images from 200 adults with moderate to severe valve problems to identify patterns that might explain why women often have w…
Matched conditions: MITRAL REGURGITATION
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Heart valve registry aims to improve future treatments
Knowledge-focused Recruiting nowThis study is collecting information from 1,000 people with symptomatic mitral valve disease, which involves a leaky or narrowed heart valve. The goal is to track how patients do after receiving a minimally invasive valve replacement procedure. The data will help doctors better u…
Matched conditions: MITRAL REGURGITATION
Sponsor: Abbott Medical Devices • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC